When nurse practitioner Amy Rabon launched Sisterhood Sanctuary’s weight management program in 2019, 25 people signed up, ...

Low doses of the injectable weight-loss medication semaglutide may improve symptoms of a hard-to-treat type of heart failure. This effect happened through direct action on the heart muscle and blood ...

India’s Dr Reddy’s Laboratories Ltd. is gearing up to launch a generic version of semaglutide — the active ingredient in Novo ...

Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance ...

New study reveals weight-loss drugs help during treatment but weight returns rapidly after stopping. Here's what they found.

A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...

A new study has found that a diabetes medicine called tirzepatide can help people lower their blood sugar and lose weight ...

GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...

Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced ...

We can't have it both ways. If we want more cutting-edge drugs, we have to protect the property rights that make them ...

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...